Periodic Reporting for period 1 - SAFEIMMUNOSUPPRESS (Development of immunosuppressive treatments with better safety)

The idea underlying the project was to prove the relevance of the development of a novel class of immunosuppressive drugs with a better safety that will selectively inhibit the proliferation of T lymphocytes by targeting a medically-relevant target named CTPS1 recently...